Linco-Spectin 100, 222/444.7 mg/g Powder for Use in Drinking Water for Pigs and Chickens

Χώρα: Ηνωμένο Βασίλειο

Γλώσσα: Αγγλικά

Πηγή: VMD (Veterinary Medicines Directorate)

Αγόρασέ το τώρα

Κατεβάστε Αρχείο Π.Χ.Π. (SPC)
26-01-2023

Δραστική ουσία:

Lincomycin, Spectinomycin

Διαθέσιμο από:

Kernfarm B.V.

Φαρμακολογική κατηγορία (ATC):

QJ01FF52

INN (Διεθνής Όνομα):

Lincomycin, Spectinomycin

Φαρμακοτεχνική μορφή:

Powder for use in drinking water

Τρόπος διάθεσης:

POM-V - Prescription Only Medicine – Veterinarian

Θεραπευτική ομάδα:

Chickens, Pigs

Θεραπευτική περιοχή:

Antimicrobial

Καθεστώς αδειοδότησης:

Authorized

Ημερομηνία της άδειας:

2015-06-24

Αρχείο Π.Χ.Π.

                                Revised: January 2021
AN: 00248/2020
Page 1 of 7
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Linco-Spectin 100, 222/444.7 mg/g Powder for use in drinking water for
pigs and chickens
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each gram contains:
ACTIVE SUBSTANCES:
Lincomycin (as lincomycin hydrochloride)
222 mg
Spectinomycin (as spectinomycin sulphate)
444.7 mg
EXCIPIENTS:
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Powder for use in drinking water.
White pale powder
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Pigs and chickens.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Pigs
For the treatment and metaphylaxis of porcine proliferative
enteropathy (ileitis) caused by
_Lawsonia intracellularis_, and associated enteric pathogens
(_Escherichia coli_) susceptible to
lincomycin and spectinomycin.
The presence of the disease in the group must be established before
the product is used.
Chickens
For the treatment and metaphylaxis of chronic respiratory disease
(CRD) caused by
_Mycoplasma gallisepticum_ and _Escherichia coli _susceptible to
lincomycin and
spectinomycin, and associated with a low mortality rate.
The presence of the disease in the flock must be established before
the product is used.
4.3
CONTRAINDICATIONS
Do not use in case of hypersensitivity to the active substances or any
of the excipients.
Do not use in case of hepatic dysfunction.
Revised: January 2021
AN: 00248/2020
Page 2 of 7
Do not allow rabbits, rodents (e.g. chinchillas, hamsters, guinea
pigs), horses or ruminants
to access to water or feeds containing lincomycin. Ingestion by these
species may result in
severe gastrointestinal effects.
Do not use in laying hens.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
In _E. coli,_ a significant part of the strains show high MIC values
(minimum inhibitory
concentrations) against the lincomycin-spectinomycin combination and
may be clinically
resistant, although no breakpoint is defined.
Due to technical constraints the susceptibility o
                                
                                Διαβάστε το πλήρες έγγραφο
                                
                            

Αναζήτηση ειδοποιήσεων που σχετίζονται με αυτό το προϊόν